Tel Aviv University-led research has found that infants prescribed acid-suppressive medications during their first six months of life had an increased risk of developing celiac disease autoimmunity ...

The early-life use of acid-suppressive therapy was significantly associated with an increased risk for celiac disease autoimmunity in a cohort analysis but not in a test-negative case-control analysis ...